Alexandre Amlie-Wolf

Alexandre Amlie-Wolf

Auto-generated profile, based on publicly available information

Alexandre Amlie-Wolf

Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BKBrian W. Kunkle
Brian W. Kunkle
T(The European Alzheimer’s Disease Initiative (Eadi)
The European Alzheimer’s Disease Initiative (Eadi)
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
RSRebecca Sims
Rebecca Sims
JBJoshua C. Bis
Joshua C. Bis
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance

28 September 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
RNRaffaella Nativio
Raffaella Nativio
YLYemin Lan
Yemin Lan
GDGreg Donahue
Greg Donahue
Simone SidoliSimone Sidoli
Simone Sidoli
ABAmit Berson
Amit Berson
SBShelley L. Berger
Shelley L. Berger

5 March 2018 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
RNRaffaella Nativio
Raffaella Nativio
GDGreg Donahue
Greg Donahue
ABAmit Berson
Amit Berson
YLYemin Lan
Yemin Lan
AAAlexandre Amlie-Wolf
Alexandre Amlie-Wolf
SBShelley L. Berger
Shelley L. Berger
Aging is the strongest risk factor for Alzheimer’s disease (AD), although the underlying mechanisms remain unclear. The chromatin state, in particular through the mark H4K16ac, has been implicated in aging and thus may play a pivotal role in age-associated neurodegeneration. Here we compare the genome-wide enrichment of H4K16ac in the lateral temporal lobe of AD individuals against both younger and elderly cognitively normal controls. We found that while normal aging leads to H4K16ac enrichment, AD entails dramatic losses of H4K16ac in the proximity of genes linked to aging and AD. Our analysis highlights the presence of three classes of AD-related changes with distinctive functional roles. Furthermore, we discovered an association between the genomic locations of significant H4K16ac changes with genetic variants identified in prior AD genome-wide association studies and with expression quantitative trait loci. Our results establish the basis for an epigenetic link between aging and AD.

8 November 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
YLYuk Yee Leung
Yuk Yee Leung
PKPavel P. Kuksa
Pavel P. Kuksa
AAAlexandre Amlie-Wolf
Alexandre Amlie-Wolf
OVOtto Valladares
Otto Valladares
LULyle H. Ungar
Lyle H. Ungar
LWLi-San Wang
Li-San Wang
Small non-coding RNAs (sncRNAs) are highly abundant RNAs, typically <100 nucleotides long, that act as key regulators of diverse cellular processes. Although thousands of sncRNA genes are known to exist in the human genome, no single database provides searchable, unified annotation, and expression information for full sncRNA transcripts and mature RNA products derived from these larger RNAs. Here, we present the Database of small human noncoding RNAs (DASHR). DASHR contains the most comprehensive information to date on human sncRNA genes and mature sncRNA products. DASHR provides a simple user interface for researchers to view sequence and secondary structure, compare expression levels, and evidence of specific processing across all sncRNA genes and mature sncRNA products in various human tissues. DASHR annotation and expression data covers all major classes of sncRNAs including microRNAs (miRNAs), Piwi-interacting (piRNAs), small nuclear, nucleolar, cytoplasmic (sn-, sno-, scRNAs, respectively), transfer (tRNAs), and ribosomal RNAs (rRNAs). Currently, DASHR (v1.0) integrates 187 smRNA high-throughput sequencing (smRNA-seq) datasets with over 2.5 billion reads and annotation data from multiple public sources. DASHR contains annotations for ∼48 000 human sncRNA genes and mature sncRNA products, 82% of which are expressed in one or more of the curated tissues. DASHR is available at http://lisanwanglab.org/DASHR.

1 September 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
A(Alzheimer Disease Genetics Consortium (ADGC)
Alzheimer Disease Genetics Consortium (ADGC)
BKBrian W. Kunkle
Brian W. Kunkle
T(The European Alzheimer’s Disease Initiative (Eadi)
The European Alzheimer’s Disease Initiative (Eadi)
C(Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)
Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

3 August 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AAAlexandre Amlie-Wolf
Alexandre Amlie-Wolf
MTMitchell Tang
Mitchell Tang
EMElisabeth E Mlynarski
Elisabeth E Mlynarski
PKPavel P. Kuksa
Pavel P. Kuksa
OVOtto Valladares
Otto Valladares
LWLi-San Wang
Li-San Wang
The majority of variants identified by genome-wide association studies (GWAS) reside in the noncoding genome, affecting regulatory elements including transcriptional enhancers. However, characterizing their effects requires the integration of GWAS results with context-specific regulatory activity and linkage disequilibrium annotations to identify causal variants underlying noncoding association signals and the regulatory elements, tissue contexts, and target genes they affect. We propose INFERNO, a novel method which integrates hundreds of functional genomics datasets spanning enhancer activity, transcription factor binding sites, and expression quantitative trait loci with GWAS summary statistics. INFERNO includes novel statistical methods to quantify empirical enrichments of tissue-specific enhancer overlap and to identify co-regulatory networks of dysregulated long noncoding RNAs (lncRNAs). We applied INFERNO to two large GWAS studies. For schizophrenia (36,989 cases, 113,075 controls), INFERNO identified putatively causal variants affecting brain enhancers for known schizophrenia-related genes. For inflammatory bowel disease (IBD) (12,882 cases, 21,770 controls), INFERNO found enrichments of immune and digestive enhancers and lncRNAs involved in regulation of the adaptive immune response. In summary, INFERNO comprehensively infers the molecular mechanisms of causal noncoding variants, providing a sensitive hypothesis generation method for post-GWAS analysis. The software is available as an open source pipeline and a web server.